Zhou H - Search Results

1

Metformin suppresses NFE2L1 pathway activation to inhibit gap junction beta protein expression in NSCLC.

Yu S, Ren H, Liu T, Han X, Guo H, Ning Q, Li Y, Zhou H, Chen M, Hu T. Yu S, et al. Among authors: zhou h. Cancer Med. 2024 Apr;13(7):e7021. doi: 10.1002/cam4.7021. Cancer Med. 2024. PMID: 38562019 Free PMC article.

2

Combining Lactate Dehydrogenase and Fibrinogen: Potential Factors to Predict Therapeutic Efficacy and Prognosis of Patients with Small-Cell Lung Cancer.

Huang W, Liu P, Zong M, Chen QQ, Zhou H, Kong H, Xie WP. Huang W, et al. Among authors: zhou h. Cancer Manag Res. 2021 May 31;13:4299-4307. doi: 10.2147/CMAR.S300153. eCollection 2021. Cancer Manag Res. 2021. PMID: 34103985 Free PMC article.

3

Protein tyrosine phosphatase PTPRO represses lung adenocarcinoma progression by inducing mitochondria-dependent apoptosis and restraining tumor metastasis.

Dai Y, Shi S, Liu H, Zhou H, Ding W, Liu C, Jin L, Xie W, Kong H, Zhang Q. Dai Y, et al. Among authors: zhou h. Cell Death Dis. 2024 Jan 5;15(1):11. doi: 10.1038/s41419-023-06375-x. Cell Death Dis. 2024. PMID: 38182570 Free PMC article.

4

Downregulation of HDAC6 mitigates lung ischemia/reperfusion injury depending on activation of Nrf2/HO-1 signaling pathway and inactivation of ERK/NF-κB signaling pathway.

Zhou H, Wu R, Li H. Zhou H, et al. Tissue Cell. 2024 Aug;89:102446. doi: 10.1016/j.tice.2024.102446. Epub 2024 Jun 15. Tissue Cell. 2024. PMID: 38936199

5

GLP-1R activation attenuates the progression of pulmonary fibrosis via disrupting NLRP3 inflammasome/PFKFB3-driven glycolysis interaction and histone lactylation.

Liu C, Zhang Q, Zhou H, Jin L, Liu C, Yang M, Zhao X, Ding W, Xie W, Kong H. Liu C, et al. Among authors: zhou h. J Transl Med. 2024 Oct 21;22(1):954. doi: 10.1186/s12967-024-05753-z. J Transl Med. 2024. PMID: 39434134 Free PMC article.

6

NLRP3 inflammasome mediates abnormal epithelial regeneration and distal lung remodeling in silica‑induced lung fibrosis.

Zhou H, Zhang Q, Liu C, Fan J, Huang W, Li N, Yang M, Wang H, Xie W, Kong H. Zhou H, et al. Int J Mol Med. 2024 Mar;53(3):25. doi: 10.3892/ijmm.2024.5349. Epub 2024 Jan 19. Int J Mol Med. 2024. PMID: 38240085 Free PMC article.

7

Silencing circLDLRAD3 Inhibits Lung Cancer Progression by Regulating the miR-497-5p/PFKP Axis.

Zhou H, Wu R, Li H. Zhou H, et al. Mol Biotechnol. 2024 Mar 1. doi: 10.1007/s12033-024-01047-3. Online ahead of print. Mol Biotechnol. 2024. PMID: 38427179

8

NLRP3 Inflammasome Mediates Silica-induced Lung Epithelial Injury and Aberrant Regeneration in Lung Stem/Progenitor Cell-derived Organotypic Models.

Zhou H, Zhang Q, Huang W, Zhou S, Wang Y, Zeng X, Wang H, Xie W, Kong H. Zhou H, et al. Among authors: zhou s. Int J Biol Sci. 2023 Mar 21;19(6):1875-1893. doi: 10.7150/ijbs.80605. eCollection 2023. Int J Biol Sci. 2023. PMID: 37063430 Free PMC article.

9

Management of massive airway hemorrhage associated with extracorporeal membrane oxygenation: A retrospective case series study.

Zhou H, Shi Q, Guo L. Zhou H, et al. Health Sci Rep. 2023 Jun 16;6(6):e1325. doi: 10.1002/hsr2.1325. eCollection 2023 Jun. Health Sci Rep. 2023. PMID: 37334040 Free PMC article.

10

An increased risk of lung cancer in combined pulmonary fibrosis and emphysema patients with usual interstitial pneumonia compared with patients with idiopathic pulmonary fibrosis alone: a systematic review and meta-analysis.

Chen Q, Liu P, Zhou H, Kong H, Xie W. Chen Q, et al. Among authors: zhou h. Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211017050. doi: 10.1177/17534666211017050. Ther Adv Respir Dis. 2021. PMID: 34011211 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,534 results

Search Page

Filters